» Articles » PMID: 16651621

Ongoing Coxsackievirus Myocarditis is Associated with Increased Formation and Activity of Myocardial Immunoproteasomes

Overview
Journal Am J Pathol
Publisher Elsevier
Specialty Pathology
Date 2006 May 3
PMID 16651621
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

A growing body of evidence indicates that viral infections of the heart contribute to ongoing myocarditis and dilated cardiomyopathy. Murine models of coxsackievirus B3 (CVB3)-induced myocarditis mimic the human disease and allow identification of susceptibility factors that modulate the course of viral myocarditis. Susceptible mouse strains develop chronic myocarditis on the basis of restricted viral replication, whereas resistant strains recover after successful virus elimination. In comparative whole-genome microarray analyses of infected hearts, several genes involved in the processing and presentation of viral epitopes were found to be uniformly up-regulated in acutely CVB3-infected susceptible mice compared with resistant animals. In particular, expression of the catalytic subunits LMP2, LMP7, and MECL-1, immunoproteasome proteins important in the generation of major histocom-patibility complex (MHC) class I-restricted peptides, was clearly enhanced in the susceptible host. Increased expression resulted in enhanced formation of immunoproteasomes and altered proteolytic activities of proteasomes in the heart. This was accompanied by a concerted up-regulation of the antigen-presenting machinery in susceptible mice. Thus, we propose that increased formation of immunoproteasomes in susceptible mice affects the generation of antigenic peptides and the subsequent T-cell-mediated immune responses.

Citing Articles

Spatiotemporal transcriptomics reveals pathogenesis of viral myocarditis.

Mantri M, Hinchman M, McKellar D, Wang M, Cross S, Parker J Nat Cardiovasc Res. 2023; 1(10):946-960.

PMID: 36970396 PMC: 10035375. DOI: 10.1038/s44161-022-00138-1.


The Functional and Mechanistic Roles of Immunoproteasome Subunits in Cancer.

Tripathi S, Vedpathak D, Ostrin E Cells. 2021; 10(12).

PMID: 34944095 PMC: 8700164. DOI: 10.3390/cells10123587.


Targeting Protein Kinase G to Treat Cardiac Proteotoxicity.

Oeing C, Mishra S, Dunkerly-Eyring B, Ranek M Front Physiol. 2020; 11:858.

PMID: 32848832 PMC: 7399205. DOI: 10.3389/fphys.2020.00858.


Induction of Proteasome Subunit Low Molecular Weight Protein (LMP)-2 Is Required to Induce Active Remodeling in Adult Rat Ventricular Cardiomyocytes.

Petersen A, Kutsche H, Nippert F, Schreckenberg R, Schulz R, Schluter K Med Sci (Basel). 2020; 8(2).

PMID: 32370048 PMC: 7353499. DOI: 10.3390/medsci8020021.


ONX 0914 Lacks Selectivity for the Cardiac Immunoproteasome in CoxsackievirusB3 Myocarditis of NMRI Mice and Promotes Virus-Mediated Tissue Damage.

Neumaier H, Harel S, Klingel K, Kaya Z, Heuser A, Kespohl M Cells. 2020; 9(5).

PMID: 32354159 PMC: 7290815. DOI: 10.3390/cells9051093.


References
1.
Luo H, Zhang J, Cheung C, Suarez A, McManus B, Yang D . Proteasome inhibition reduces coxsackievirus B3 replication in murine cardiomyocytes. Am J Pathol. 2003; 163(2):381-5. PMC: 1868224. DOI: 10.1016/S0002-9440(10)63667-X. View

2.
Henke A, Huber S, Stelzner A, Whitton J . The role of CD8+ T lymphocytes in coxsackievirus B3-induced myocarditis. J Virol. 1995; 69(11):6720-8. PMC: 189582. DOI: 10.1128/JVI.69.11.6720-6728.1995. View

3.
Gebhard J, Perry C, Harkins S, Lane T, Mena I, Asensio V . Coxsackievirus B3-induced myocarditis: perforin exacerbates disease, but plays no detectable role in virus clearance. Am J Pathol. 1998; 153(2):417-28. PMC: 1852975. DOI: 10.1016/S0002-9440(10)65585-X. View

4.
Eggers M, Ruppert T, Kloetzel P, Koszinowski U . The cleavage preference of the proteasome governs the yield of antigenic peptides. J Exp Med. 1995; 182(6):1865-70. PMC: 2192259. DOI: 10.1084/jem.182.6.1865. View

5.
Wherry E, Blattman J, Murali-Krishna K, van der Most R, Ahmed R . Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment. J Virol. 2003; 77(8):4911-27. PMC: 152117. DOI: 10.1128/jvi.77.8.4911-4927.2003. View